Jacques Dessureault

Former President & Director at Valeant Canada Ltd.

Jacques Dessureault

Jacques Dessureault

Former President & Director at Valeant Canada Ltd.

Overview
Career Highlights

Valeant Canada Ltd.
Bausch Health Cos., Inc.
Valeant Pharmaceuticals International Corp.

RelSci Relationships

724

Number of Boards

3

Birthday

1963

Age

58

Relationships
RelSci Relationships are individuals Jacques Dessureault likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director, Executive Vice President & General Counsel at Valeant Canada Ltd.

Relationship likelihood: Strong

Secretary & Director at Valeant Pharmaceuticals Australasia Pty Ltd.

Relationship likelihood: Strong

Secretary & Director at Valeant Canada Ltd.

Relationship likelihood: Strong

Chief Financial Officer & Executive Vice President at Aton Pharma, Inc.

Relationship likelihood: Strong

Former Finance Director & Chief Financial Officer, Eastern Europe & Central Asia at Procter & Gamble Co.

Relationship likelihood: Strong

President & Chief Executive Officer at Crescita Therapeutics, Inc.

Relationship likelihood: Strong

Former President at Valeant Canada Ltd.

Relationship likelihood: Strong

Vice President, Sales & Marketing at Crescita Therapeutics, Inc.

Relationship likelihood: Strong

Executive Partner, Chief Operating Officer at Flagship Pioneering

Relationship likelihood: Average

President & Chief Operating Officer at CareCentrix, Inc.

Relationship likelihood: Average

Paths to Jacques Dessureault
Potential Connections via
Relationship Science
You
Jacques Dessureault
Former President & Director at Valeant Canada Ltd.
Career History
President & Director
2012 - 2017

Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada.

President & General Manager
Prior

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

President & General Manager
Prior

Valeant Pharmaceuticals International Corp. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jacques Dessureault. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jacques Dessureault's profile does not indicate a business or promotional relationship of any kind between RelSci and Jacques Dessureault.